As GLP-1 popularity, use, and price continues to rise, pharmacy industry stakeholders are attempting to guide pharmacists and patients around the complexities of this drug class.
Rae McMahan
Advertisement
Rae McMahan, senior vice president of payor solutions at Prescryptive Health
Articles by Rae McMahan
In part 3 of our interview with Rae McMahan, she explores her role at Prescryptive Health and how she’s helping pharmacy stakeholders navigate complex GLP-1 prescription drug benefits.
Through her work as senior vice president of payor solutions at Prescryptive Health, Rae McMahan shares insights into how increased GLP-1 popularity and costs impact pharmacies.
Rae McMahan, senior vice president of payor solutions at Prescryptive Health, discusses GLP-1 access, advertising, and the challenges that often accompany this drug class.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
2
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
5
